Inicio › Cáncer (todos los tipos) › Ohio › Cincinnati
Ensayos clínicos de Cáncer (todos los tipos) en Cincinnati, OH
26 estudios para Cáncer (todos los tipos) buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- y 1 más
Pan Tumor Rollover Study
ReclutandoFase 2
- Oncology Hematology Care, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
ReclutandoFase 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · A 8 mi de distancia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- USO - Oncology Hematology Care, Cincinnati
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- Oncology Hematology Care, Inc., Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
ReclutandoFase 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · A 15 mi de distancia
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Edgewood · A 8 mi de distancia
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
ReclutandoFase 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Registry Study for Radiation Therapy Outcomes
ReclutandoEstudio observacional
- University of Cincinnati Medical Center, Cincinnati
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Reclutando
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ReclutandoFase 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · A 15 mi de distancia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · A 15 mi de distancia
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ReclutandoEstudio observacional
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
ReclutandoEstudio observacional
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
ReclutandoEstudio observacional
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
ReclutandoFase 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
ReclutandoFase 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
ReclutandoEstudio observacional
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ReclutandoFase 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
ReclutandoEstudio observacional
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
ReclutandoEstudio observacional
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutando
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · A 15 mi de distancia
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX124 estudios
- New York City, NY105 estudios
- Boston, MA90 estudios
- Los Angeles, CA73 estudios
- Nashville, TN65 estudios
- Durham, NC61 estudios
- Washington, DC60 estudios
- Philadelphia, PA57 estudios
- Arlington, VA52 estudios
- Chicago, IL51 estudios
- St. Louis, MO51 estudios
- Atlanta, GA49 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer de seno24 estudios
- Fallo cardíaco22 estudios
- Cáncer metastásico21 estudios
- Cáncer del colon y del recto20 estudios
- Obesidad20 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de próstata19 estudios
- Cáncer de ovario18 estudios
- Cáncer de pulmón18 estudios
- Mieloma múltiple17 estudios
- Enfermedad cardiovascular16 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.